How to read the Zepbound dosage chart
Every Zepbound treatment begins at 2.5 mg once a week for four weeks. Then the dose goes to 5 mg, and from there it can rise by 2.5 mg, each step after at least four weeks on the current dose, up to 15 mg (Zepbound prescribing information).
Only three rows are places to stay. The label names 5, 10 and 15 mg as maintenance doses for weight, and 10 or 15 mg for obstructive sleep apnea; 7.5 and 12.5 mg are steps on the way. The label asks prescribers to pick the maintenance dose based on how you respond and what you tolerate, so you don’t have to reach 15 mg. Our Zepbound dosage schedule guide goes through each step in more detail.
What each maintenance dose did in the trial
In SURMOUNT-1, adults with obesity and without diabetes were assigned one maintenance dose and stayed on it (Jastreboff et al., NEJM 2022):
| Maintenance dose | Average weight lost after 72 weeks |
|---|---|
| 5 mg | 15.0% |
| 10 mg | 19.5% |
| 15 mg | 20.9% |
| Placebo | 3.1% |
These are averages, alongside diet and exercise advice; individual results vary a lot.
When a dose is hard to tolerate
Digestive side effects rise with the dose. In the weight-reduction trials, nausea affected 25%, 29% and 28% of people on 5, 10 and 15 mg, against 8% on placebo (Zepbound prescribing information). The label gives two levers: staying longer on a dose before stepping up, and, if a maintenance dose isn’t tolerated, considering a lower maintenance dose.
An expert consensus on this class of medicines adds the practical order: change how you eat first (smaller meals, stop as soon as you’re full, less fatty food, fluids sipped between meals), then hold the dose, then step back to the previous one and go up more slowly (Gorgojo-Martínez et al., J Clin Med 2022). Call your prescriber promptly for severe stomach pain that doesn’t go away, sometimes reaching through to the back, or vomiting that keeps you from holding down fluids. The tirzepatide dosage chart explains how the trials handled this, step by step.
Missed doses, late doses and changing your day
| Situation | What to do |
|---|---|
| 4 days (96 hours) or less since the missed day | Take it as soon as possible |
| More than 4 days | Skip it; take the next dose on your usual day |
| Moving your shot day | Allowed if the two doses are at least 3 days (72 hours) apart |
| Missed several weeks in a row | No rule in the label; ask your prescriber which dose to restart on |
For example, if your shot day is Monday and you remember on Thursday, you’re within four days: take it Thursday, then go back to Mondays as long as the next dose is at least three days later. If you remember on Saturday, skip it and wait for Monday.
For longer breaks, the trials offer a guide: people restarted at the same dose after one or two missed doses if they’d tolerated it, and at 5 mg after three or more, then stepped up again (Lilly Medical). That’s trial practice, not a label instruction, so check with your prescriber first.
Pens, vials and KwikPens
| Device | Weekly doses inside | Dose volume | Out of the refrigerator |
|---|---|---|---|
| Single-dose pen | 1 | 0.5 mL | Up to 30 °C (86 °F) for a total of 21 days |
| Single-dose vial | 1 | 0.5 mL | Up to 30 °C (86 °F) for a total of 21 days |
| KwikPen | 4 | 0.6 mL | Discard 30 days after first use or after 4 doses |
| Multi-dose vial | 4 | 0.6 mL | Discard 30 days after first use or after 4 doses |
Single-dose pens and vials come in all six strengths. Before use, every device is kept in the refrigerator at 2–8 °C (36–46 °F). With vials, use a syringe suitable for the dose and a new syringe and needle for every injection. If your prescription moves you to a different device, the label asks for training on the new one; the KwikPen isn’t recommended for self-injection by people with visual impairment unless their provider decides they can use it (Zepbound prescribing information).
Inject under the skin of the abdomen or thigh, or the back of the upper arm if someone else gives the shot, and rotate the site each week.
Milligrams, not units
Every dose on this page is in milligrams, which is how Zepbound is prescribed. Syringe “units” only mean something for a specific vial’s concentration, which is why a units chart from one source can be badly wrong for another. Lilly also doesn’t recommend splitting a dose or counting KwikPen clicks to take part of one: it hasn’t been studied, and the instructions only cover the full dose (Lilly Medical).
Before surgery, during pregnancy, and with the pill
- Surgery or sedation: tell the team doing any planned procedure that you take Zepbound; the label warns about breathing in stomach contents under anesthesia or deep sedation.
- Pregnancy: stop Zepbound when a pregnancy is recognized, and talk to your prescriber if you’re planning one.
- Birth control pills: switch to a non-oral method, or add a barrier method, for four weeks after starting and after each dose increase.
Keeping a record of each step
In Mingo, every shot is saved with its dose and injection site, the weight chart marks the first shot of each new dose and colors the line by the dose you were on, and side effects are rated from 0 to 10 on the same timeline. After a few months that shows which step did what, and the dates of your increases make the birth-control window easy to follow. Mingo doesn’t decide your dose; your prescriber does, and the record helps that conversation.


